Skip to main content
logo
Ocular Therapeutix logo
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.59
+0.05 (0.66%)
Oct 12, 2026, 12:37 PM EDT - Market open

Ocular Therapeutix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,6672,5861,343492216534
Market Cap Growth
-19.56%92.64%173.13%127.16%-59.47%-65.74%
Enterprise Value
1,1482,319991464155413
Last Close Price
7.5412.148.544.462.816.97

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
31.8149.7921.078.414.2012.27
PB Ratio
3.183.954.265.396.126.07
P/TBV Ratio
3.183.954.265.396.126.07

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
21.8444.6315.547.943.019.50

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.120.240.921.820.67
Net Debt / Equity Ratio
-1.00-1.01-1.00-1.23-1.07-1.19
Net Debt / EBITDA Ratio
1.682.482.011.420.501.39
Net Debt / FCF Ratio
2.043.042.331.470.601.58
Asset Turnover
0.090.080.180.290.290.19
Inventory Turnover
67.0761.6849.8631.0135.9844.46
Quick Ratio
12.7915.1110.276.363.947.04
Current Ratio
13.1115.3910.666.664.137.26
Return on Equity (ROE)
-72.99%-54.85%-95.21%-127.64%-115.16%-7.99%
Return on Assets (ROA)
-34.95%-26.66%-28.32%-25.66%-27.76%-20.90%
Return on Capital Employed (ROCE)
-50.50%-35.70%-38.60%-37.90%-66.70%-43.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.20%-10.28%-14.41%-16.42%-32.83%-1.23%
FCF Yield
-15.41%-8.39%-10.13%-15.53%-29.26%-12.50%
Buyback Yield / Dilution
-26.40%-18.31%-84.90%-3.57%-0.59%-35.24%
SEC Filings: 10-K · 10-Q